Towards Healthcare
U.S. Oncology Pharmaceutical Market Size, Emerging Trends and Insights

U.S. Oncology Pharmaceutical Market Top Players, Record Investments, and Next-Gen Antibody-Drug Conjugates

The U.S. oncology pharmaceutical market is expanding due to increasing cancer awareness as well as growing cancer drug development. 

Content

  • Insight Code: 5986
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The U.S. Oncology Pharmaceuticals Market reaching new heights by 2034, driven by consumer shifts and rapid biotech advancements.

The U.S. oncology pharmaceutical market is significantly growing due to the increasing innovations.

The U.S. oncology pharmaceutical market includes five segments such as by drug class, by therapy type, by indication, by dosage form, and by distribution channel.

Some key players include Roche, Merck & Co., Bristol-Myers Squibb, and Johnson & Johnson.

The different types of cancer therapies are chemotherapy, targeted therapy, immunotherapy, and hormonal therapy.

Increasing research and development is the factor that drives the market growth.

American Cancer Society, Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions